Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed350%
recruiting233%
unknown117%

Recent Activity

2 active trials
Showing 5 of 6
completednot_applicable

The Influence of the Individual Auditory-cognitive Need on the Aided Benefit Using Different Feature Settings

NCT06420037
recruiting

Study of CAR-T Therapy in Older Patients

NCT04300998
completednot_applicable

Susceptibility to Pathological Gambling

NCT01528982
recruiting

Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults

NCT06345625
completednot_applicable

Cognitive Function and Autonomic Regulation in Patients With Migraine

NCT04272229
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06420037Not Applicable

The Influence of the Individual Auditory-cognitive Need on the Aided Benefit Using Different Feature Settings

Completed
NCT04300998

Study of CAR-T Therapy in Older Patients

Recruiting
NCT01528982Not Applicable

Susceptibility to Pathological Gambling

Completed
NCT06345625

Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults

Recruiting
NCT04272229Not Applicable

Cognitive Function and Autonomic Regulation in Patients With Migraine

Completed
NCT04234776Phase 4

Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6